Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Exclusives

More »

Video Channel

More »

Inside Story Behind Glybera's Development and Approval

Late last year the European Medicines Agency granted marketing approval for the Western world's first gene therapy product, Glybera. During this SKYPE interview, James M. Wilson, M.D., Ph.D., one of the researchers who led the Glybera team, discusses the ups and downs and ins and outs of not only developing the new therapeutic but also gaining regulatory approval for the novel product. JMW is an inventor on the AAV1 patent and will receive royalties from the sales of Glybera.

Application Notes

More »

Leverage our free Application Note Library to make smarter technology and service purchasing decisions. We will post technical white papers and application notes from leading tool and service providers to keep you up-to-date.

The App Note Library

The Lists

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll